Oscar Health’s third quarter results fell short of Wall Street’s expectations, reflecting persistent challenges in the individual health insurance market. Management attributed the underperformance mainly to increased market morbidity, which refers to a higher proportion of sicker individuals entering the risk pool, driven in part by Medicaid redeterminations and program integrity efforts. CEO Mark Bertolini described 2025 as a “reset moment” for the market, noting, “Overall risk adjustment data from Wakely in the third quarter show continued higher market morbidity, which we attribute to Medicaid lives entering the market and the initial impacts of program integrity efforts.” The company also pointed to disciplined cost controls and improved administrative expense ratios as partial offsets to these headwinds.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 13.8% in the afternoon session after investors reacted to a proposal to redirect healthcare funding away from insurers and a third-quarter earnings report showing a significant net loss.
Health insurance company Oscar Health (NYSE:OSCR) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 23.2% year on year to $2.99 billion. On the other hand, the company’s full-year revenue guidance of $12.1 billion at the midpoint came in 0.5% above analysts’ estimates. Its GAAP loss of $0.53 per share was 6.8% below analysts’ consensus estimates.
Oscar Health (OSCR) reported mixed Q3 2025 results, missing revenue estimates but beating on EPS. The stock surged as investors focused on strong membership growth and reaffirmed full-year guidance.
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
Health insurance company Oscar Health (NYSE:OSCR) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 23.2% year on year to $2.99 billion. On the other hand, the company’s full-year revenue guidance of $12.1 billion at the midpoint came in 0.5% above analysts’ estimates. Its GAAP loss of $0.53 per share was 6.8% below analysts’ consensus estimates.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 7.8% in the afternoon session after a rival, Molina Healthcare, slashed its profit forecast, citing rising medical costs and sparking sector-wide concerns. Molina cut its 2025 adjusted profit outlook from a previous target of $19 per share to about $14, attributing the change to "unprecedented" medical claims in its ACA Marketplace plans. The company noted that competitors, including Oscar Health, faced similar cost pressures. This news caused a ripple effect across the industry, with Molina's stock plunge leading declines for other ACA-focused insurers. Oscar's shares fell as investors grew worried about the impact of these elevated costs on the company's own profitability.
